• Je něco špatně v tomto záznamu ?

Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles--a preliminary study

K. Malicková, R. Jarosová, K. Rezábek, T. Fait, J. Masata, I. Janatková, T. Zima, M. Kalousová,

. 2010 ; 56 (9-10) : 377-84.

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026073

BACKGROUND: To investigate inflammatory processes during ovarian hyperstimulation, we have studied the soluble receptor for advanced glycation end products (sRAGE) levels in sera and follicular fluids of women undergoing in vitro fertilisation (IVF) cycle. METHODS: A total of thirty-three women undergoing IVF treatment were recruited, the number of follicles in investigated IVF cycles was 18 +/- 10 (mean +/- SD), oocytes 12 +/- 8, and the clinical pregnancy rate was 42% (14/33). The control group of serum samples was comprised of 35 healthy female blood donors. Sera and follicular fluids were examined for sRAGE levels by enzyme-linked immunosorbent assay (sRAGE ELISA, Quantikine, R&D Systems). RESULTS: Serum levels of sRAGE in women after ovarian hyperstimulation and induction of ovulation (1039 +/- 493 pg/mL) were significantly lower than in healthy blood donors (1535 +/- 438 pg/mL), p = 0.045. Follicular sRAGE levels (4355 +/- 1100 pg/mL) were significantly higher than serum levels (1039 +/- 493 pg/ml), p < 0.001. Serum sRAGE levels showed significant negative correlation with the number of stimulated follicles (r = -0.71, p = 0.01) and retrieved oocytes (r = -0.54, p = 0.048). Women who successfully conceived after the IVF showed significantly higher sRAGE levels in follicular fluid (4595 +/- 925 pg/mL) compared to women who did not conceive (3986 +/- 806 pg/mL), p = 0.031. CONCLUSIONS: Concentration of sRAGE in follicular fluid is several-fold higher compared to serum and most other biological fluids investigated until this time. It supports the hypothesis that mammalian ovulation can be compared to an inflammatory event. A significant negative correlation of serum sRAGE with the yield of follicles and oocytes, together with the high follicular sRAGE levels, in particular in women who conceive after the IVF, could be explained by the essential outflow of sRAGE to the follicular compartment.

000      
00000naa a2200000 a 4500
001      
bmc12026073
003      
CZ-PrNML
005      
20160603133900.0
007      
ta
008      
120817s2010 gw f 000 0#eng||
009      
AR
035    __
$a (PubMed)21086782
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Malicková, Karin $u Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
245    10
$a Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles--a preliminary study / $c K. Malicková, R. Jarosová, K. Rezábek, T. Fait, J. Masata, I. Janatková, T. Zima, M. Kalousová,
520    9_
$a BACKGROUND: To investigate inflammatory processes during ovarian hyperstimulation, we have studied the soluble receptor for advanced glycation end products (sRAGE) levels in sera and follicular fluids of women undergoing in vitro fertilisation (IVF) cycle. METHODS: A total of thirty-three women undergoing IVF treatment were recruited, the number of follicles in investigated IVF cycles was 18 +/- 10 (mean +/- SD), oocytes 12 +/- 8, and the clinical pregnancy rate was 42% (14/33). The control group of serum samples was comprised of 35 healthy female blood donors. Sera and follicular fluids were examined for sRAGE levels by enzyme-linked immunosorbent assay (sRAGE ELISA, Quantikine, R&D Systems). RESULTS: Serum levels of sRAGE in women after ovarian hyperstimulation and induction of ovulation (1039 +/- 493 pg/mL) were significantly lower than in healthy blood donors (1535 +/- 438 pg/mL), p = 0.045. Follicular sRAGE levels (4355 +/- 1100 pg/mL) were significantly higher than serum levels (1039 +/- 493 pg/ml), p < 0.001. Serum sRAGE levels showed significant negative correlation with the number of stimulated follicles (r = -0.71, p = 0.01) and retrieved oocytes (r = -0.54, p = 0.048). Women who successfully conceived after the IVF showed significantly higher sRAGE levels in follicular fluid (4595 +/- 925 pg/mL) compared to women who did not conceive (3986 +/- 806 pg/mL), p = 0.031. CONCLUSIONS: Concentration of sRAGE in follicular fluid is several-fold higher compared to serum and most other biological fluids investigated until this time. It supports the hypothesis that mammalian ovulation can be compared to an inflammatory event. A significant negative correlation of serum sRAGE with the yield of follicles and oocytes, together with the high follicular sRAGE levels, in particular in women who conceive after the IVF, could be explained by the essential outflow of sRAGE to the follicular compartment.
650    _2
$a dospělí $7 D000328
650    _2
$a dárci krve $7 D001782
650    _2
$a ELISA $7 D004797
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fertilizace $7 D005306
650    _2
$a fertilizace in vitro $7 D005307
650    _2
$a folikulární tekutina $x metabolismus $x fyziologie $7 D015571
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x patofyziologie $7 D007249
650    _2
$a ovariální folikul $x fyziologie $7 D006080
650    _2
$a indukce ovulace $7 D010062
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a těhotenství $7 D011247
650    _2
$a receptory imunologické $x krev $x metabolismus $7 D011971
650    _2
$a referenční hodnoty $7 D012016
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jarosová, Radka
700    1_
$a Řežábek, Karel, $d 1955- $7 jn20000403066
700    1_
$a Fait, Tomáš, $d 1971- $7 xx0053331
700    1_
$a Masata, Jaromir
700    1_
$a Janatková, Ivana
700    1_
$a Zima, Tomás
700    1_
$a Kalousová, Marta
773    0_
$w MED00009480 $t Clinical laboratory $x 1433-6510 $g Roč. 56, č. 9-10 (2010), s. 377-84
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21086782 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20160603134023 $b ABA008
999    __
$a ok $b bmc $g 948115 $s 783419
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 56 $c 9-10 $d 377-84 $i 1433-6510 $m Clinical laboratory $n Clin Lab $x MED00009480
LZP    __
$a Pubmed-20120817/10/04

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...